Exhibit 10.2
SECURITIES PURCHASE
AGREEMENT
This Securities Purchase Agreement
(this “ Agreement ”) is dated as of
August 25, 2009, between Pacwest Bancorp, a Delaware
corporation (the “ Company ”), and each
purchaser identified on the signature pages hereto (each,
including its successors and assigns, a “ Purchaser
” and collectively the “ Purchasers
”).
WHEREAS, subject to the terms and
conditions set forth in this Agreement and pursuant to an effective
registration statement under the Securities Act (as defined below),
the Company desires to issue and sell to each Purchaser, and each
Purchaser, severally and not jointly, desires to purchase from the
Company, securities of the Company as more fully described in this
Agreement.
NOW, THEREFORE, IN CONSIDERATION of
the mutual covenants contained in this Agreement, and for other
good and valuable consideration the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as
follows:
ARTICLE I.
DEFINITIONS
1.1
Definitions . For all purposes of this Agreement, the
following terms have the meanings set forth in this
Section 1.1:
“ Agreement ”
shall have the meaning ascribed to such term in the
Preamble.
“ Action ” shall
have the meaning ascribed to such term in
Section 3.1(j).
“ Affiliate ”
means any Person that, directly or indirectly through one or more
intermediaries, controls or is controlled by or is under common
control with a Person as such terms are used in and construed under
Rule 405 under the Securities Act.
“ Bank ” shall
have the meaning ascribed to such term in the
Section 3.1(a).
“ Board of Directors
” means the board of directors of the Company.
“ Business Day ”
means any day except any Saturday, any Sunday, any day which is a
federal legal holiday in the United States or any day on which
banking institutions in the State of New York or the State of
California are authorized or required by law or other governmental
action to close.
“ Closing ” means
the closing of the purchase and sale of the Securities pursuant to
Section 2.1.
“ Closing Date ”
shall have the meaning ascribed to such term in
Section 2.1.
“ Commission ”
means the United States Securities and Exchange
Commission.
“ Common Stock ”
means the common stock of the Company, par value $0.01 per share,
and any other class of securities into which such securities may
hereafter be reclassified or changed.
“ Common Stock
Equivalents ” means any securities of the Company or its
Subsidiaries which would entitle the holder thereof to acquire at
any time Common Stock, including, without limitation, any debt,
preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exercisable or exchangeable for,
or otherwise entitles the holder thereof to receive, Common
Stock.
“ Company ” shall
have the meaning ascribed to such term in the Preamble.
“ Company Counsel
” means Sullivan & Cromwell LLP, with offices
located at 1888 Century Park East, Suite 2100, Los Angeles,
California 90067.
“ DWAC ” shall
have the meaning ascribed to such term in
Section 2.2(a)(iii).
“ Exchange Act ”
means the Securities Exchange Act of 1934, as amended, and the
rules and regulations promulgated thereunder.
“ Exempt Issuance
” means the issuance of (a) shares of Common Stock or
options to employees, officers or directors of the Company pursuant
to any 401(k), stock or option plan duly adopted for such purpose
by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee
directors established for such purpose, (b) securities upon
the exercise or exchange of or conversion of any Securities issued
hereunder and/or other securities exercisable or exchangeable for
or convertible into shares of Common Stock issued and outstanding
on the date of this Agreement; provided , however ,
that such securities have not been amended since the date of this
Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such
securities, (c) securities pursuant to stock splits, stock
dividends or distributions, recapitalizations and similar events
affecting the Common Stock and (d) securities pursuant to
acquisitions or strategic transactions approved by a majority of
the disinterested directors of the Company; provided ,
however , that any such issuance shall only be to a Person
(or to the equityholders of a Person) which is, itself or through
its subsidiaries, an operating company or the holder of assets in a
business synergistic with the business of the Company;
provided , further , that, any such transaction shall
not include a transaction in which the Company is issuing
securities primarily for the purpose of raising capital or to an
entity whose primary business is investing in
securities.
“ GAAP ” shall
have the meaning ascribed to such term in
Section 3.1(h).
“ Liens ” means a
lien, charge, security interest, encumbrance, right of first
refusal, preemptive right or other restriction, other than
restrictions imposed by securities laws.
“ Material Adverse
Effect ” means: (a) a material adverse effect on the
Company’s ability to perform in any material respect its
obligations under any Transaction Document, or (b) a material
adverse effect on the results of operations, assets, business
or
2
financial condition of the Company
and its Subsidiaries, taken as a whole; provided ,
however , that none of the following, in and of itself or
themselves, shall constitute a Material Adverse Effect:
(i) changes in the economy or financial markets generally in
the United States or changes that are the result of acts of war or
terrorism; (ii) changes that are the result of factors
generally affecting the banking industry in which the Company and
its Subsidiaries operate; and (iii) a decline in the price of
the Company’s Common Stock on the Trading Market; provided,
that, the exception in this clause (iii) shall not prevent or
otherwise affect a determination that any change, effect,
circumstance or development underlying such decline has resulted
in, or contributed to, a Material Adverse Effect.
“ Material Permits
” shall have the meaning ascribed to such term in
Section 3.1(m).
“ Per Share Exercise
Price ” equals $20.20 (being 110% of the Per Share
Purchase Price), subject to adjustment as set forth in the
Warrant.
“ Per Share Purchase
Price ” equals $18.36, subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and
other similar transactions of the Common Stock that occur after the
date of this Agreement and on or prior to the Closing
Date.
“ Person ” means
an individual or corporation, partnership, trust, incorporated or
unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or
subdivision thereof) or other entity of any kind.
“ Proceeding ”
means an action, claim, suit, investigation or proceeding
(including, without limitation, an informal investigation or
partial proceeding, such as a deposition), whether commenced or
threatened.
“ Prospectus ”
means the base prospectus filed with the Registration
Statement.
“ Prospectus Supplement
” means the supplement to the Prospectus complying with
Rule 424(b) of the Securities Act that is filed with the
Commission and delivered by the Company to each Purchaser prior to
or at the Closing.
“ Purchaser ”
shall have the meaning ascribed to such term in the
Preamble.
“ Purchaser Party
” shall have the meaning ascribed to such term in
Section 4.5.
“ Registration
Statement ” means the effective registration statement,
as amended, filed with the Commission (File No. 333-159999),
which registers the sale of the Securities to the
Purchasers.
“ Required Approvals
” shall have the meaning ascribed to such term in
Section 3.1(e).
3
“ Rule 144 ”
means Rule 144 promulgated by the Commission pursuant to the
Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the
Commission having substantially the same effect as such
Rule.
“ Rule 424 ”
means Rule 424 promulgated by the Commission pursuant to the
Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the
Commission having substantially the same purpose and effect as such
Rule.
“ SEC Reports ”
shall have the meaning ascribed to such term in
Section 3.1(h).
“ Securities ”
means the Shares, the Warrants and the Warrant Shares.
“ Securities Act
” means the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder.
“ Series A
Warrants ” means, collectively, the Series A Common
Stock greenshoe warrants delivered to the Purchasers at the Closing
in accordance with Section 2.2(a) hereof, which shall be
exercisable commencing on the Closing Date and have a term of
exercise equal to six months from the Closing Date, in the form of
Exhibit A attached hereto.
“ Series B
Warrants ” means, collectively, the Series B Common
Stock greenshoe warrants delivered to the Purchasers at the Closing
in accordance with Section 2.2(a) hereof, which shall be
exercisable commencing on the Closing Date and have a term of
exercise equal to one year from the Closing Date, in the form of
Exhibit A attached hereto.
“ Shares ” means
the shares of Common Stock issued or issuable to each Purchaser
pursuant to this Agreement.
“ Short Sales ”
means all “short sales” as defined in Rule 200 of
Regulation SHO under the Exchange Act (but shall not be deemed to
include the location and/or reservation of borrowable shares of
Common Stock).
“ Subscription Amount
” means, as to each Purchaser, the aggregate amount in cash
to be paid for the Shares and Warrants purchased hereunder as
specified below such Purchaser’s name on the signature
page hereto executed by such Purchaser and next to the heading
“Subscription Amount,” in United States
dollars.
“ Subsidiary ”
means any subsidiary of the Company as set forth in the SEC
Reports, and shall, where applicable, also include any direct or
indirect subsidiary of the Company formed or acquired after the
date hereof.
“ Trading Day ”
means a day on which the Trading Market is open for
trading.
4
“ Trading Market
” means the Nasdaq Global Select Market, (or any successors
thereto).
“ Transaction Documents
” means this Agreement, the Warrants and any other documents
or agreements executed in connection with the transactions
contemplated hereunder.
“ Transfer Agent
” means Wells Fargo Shareowner Services, the current transfer
agent of the Company, with a mailing address of P.O. Box
64874, St. Paul, MN 55164-0874 and a facsimile number of (651)
450-4078, and any successor transfer agent of the
Company.
“ Warrants ”
means the Series A Warrants and the Series B
Warrants.
“ Warrant Shares
” means the shares of Common Stock issuable upon exercise of
the Warrants.
“ WS ” means
Weinstein Smith LLP, with offices located at 420 Lexington Avenue,
Suite 2620, New York, New York 10170-0002.
ARTICLE II.
PURCHASE AND
SALE
2.1
Closing . At the Closing, upon the terms and subject
to the conditions set forth herein, substantially concurrent with
the execution and delivery of this Agreement by the parties hereto,
the Company agrees to sell, and the Purchasers, severally and not
jointly, agree to purchase, (a) up to an aggregate of
$50,000,000 Shares and (ii) Warrants to purchase such number
of additional shares of Common Stock as determined in accordance
with Section 2.2(a), as to each Purchaser for such
Subscription Amount as is specified below such Purchaser’s
name on the signature page hereto. As soon as
practicable, but in no event more than 24 hours, after the
satisfaction or waiver of the conditions set forth in
Section 2.3 (other than those conditions that by their nature
are to be satisfied at the Closing but subject to the fulfillment
or waiver of those conditions), the Closing shall occur at the
offices of Sullivan & Cromwell LLP, 1888 Century Park
East, Los Angeles, California 90067, or such other location as the
parties shall mutually agree. The date on which the Closing
occurs is referred to herein as the “ Closing Date
.”
2.2
Deliveries .
(a)
On or prior to the Closing Date, the Company shall deliver or cause
to be delivered to each Purchaser the following:
(i)
this Agreement duly executed by the Company;
(ii)
a legal opinion of Company Counsel, substantially in the form of
Exhibit B-1 attached hereto;
5
(iii)
a legal opinion of Jared M. Wolff, General Counsel to the Company,
substantially in the form of Exhibit B-2 attached
hereto;
(iv)
a copy of the irrevocable instructions to the Transfer Agent
instructing the Transfer Agent to deliver via the Depository Trust
Company Deposit Withdrawal Agent Commission System (“
DWAC ”) that number of Shares equal to such
Purchaser’s Subscription Amount divided by the Per Share
Purchase Price, registered in the name of such
Purchaser;
(v)
a Series A Warrant registered in the name of such Purchaser to
purchase up to a number of shares of Common Stock equal to
50 % of the Shares issuable to the
Purchaser on the Closing Date, with an exercise price equal to the
Per Share Exercise Price (such Warrant certificate may be delivered
within three Trading Days of the Closing Date);
(vi)
a Series B Warrant registered in the name of such Purchaser to
purchase up to a number of shares of Common Stock equal to
50 % of the Shares issuable to the
Purchaser on the Closing Date, with an exercise price equal to the
Per Share Exercise Price (such Warrant certificate may be delivered
within three Trading Days of the Closing Date); and
(vii)
the Prospectus and Prospectus Supplement (which may be delivered in
accordance with Rule 172 under the Securities
Act).
(b)
On or prior to the Closing Date, each Purchaser shall deliver or
cause to be delivered to the Company the following:
(i)
this Agreement duly executed by such Purchaser; and
(ii)
such Purchaser’s Subscription Amount by wire transfer of
immediately available funds to the account as specified in writing
by the Company.
2.3
Closing Conditions .
(a)
The obligations of the Company hereunder in connection with the
Closing are subject to the following conditions being
met:
(i)
the accuracy in all material respects, when made and on the Closing
Date (unless as of a specific date therein), of the representations
and warranties of the Purchasers contained herein;
(ii)
the performance in all material respects of all obligations,
covenants and agreements of each Purchaser hereunder required to be
performed on or prior to the Closing Date; and
(iii)
the delivery by each Purchaser of the item set forth in
Section 2.2(b)(i) of this Agreement.
6
(b)
The respective obligations of the Purchasers hereunder in
connection with the Closing are subject to the following conditions
being met:
(i)
the accuracy in all material respects, when made and on the Closing
Date (unless as of a specific date therein), of the representations
and warranties of the Company contained herein;
(ii)
the performance in all material respects of all obligations,
covenants and agreements of the Company hereunder required to be
performed at or prior to the Closing Date; and
(iii)
the delivery by the Company of the items set forth in
Section 2.2(a)(i), (ii) and (iii) of this
Agreement.
ARTICLE III.
REPRESENTATIONS
AND WARRANTIES
3.1
Representations and Warranties of the Company . Except
as disclosed in reasonable detail in the SEC Reports, the Company
hereby represents and warrants to each Purchaser as of the date
hereof:
(a)
Subsidiaries . All of the direct and indirect
significant subsidiaries (as defined in Rule 1-02(w) of
Regulation S-X) of the Company are set forth in the SEC
Reports. The Company owns, directly or indirectly, all of the
capital stock or other equity interests of Pacific Western Bank, a
California state-chartered bank (the “ Bank ”),
free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of the Bank are validly issued and are
fully paid, non-assessable and were issued free of preemptive and
similar rights to subscribe for or purchase securities.
(b)
Organization and Qualification . The Company and each
of its Subsidiaries is an entity duly incorporated or otherwise
organized, validly existing and in good standing under the laws of
the jurisdiction of its incorporation or organization, with the
requisite power and authority to own and use its properties and
assets and to carry on its business as currently conducted.
Neither the Company nor any Subsidiary is in violation or default
of any of the provisions of its respective certificate or articles
of incorporation, bylaws or other organizational or charter
documents. Each of the Company and its Subsidiaries is duly
qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the
nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so
qualified or in good standing, as the case may be, would not
reasonably be expected to result in a Material Adverse Effect and,
to the Company’s actual knowledge, no Proceeding has been
instituted in any such jurisdiction revoking, limiting or
curtailing or seeking to revoke, limit or curtail such power and
authority or qualification.
(c)
Authorization; Enforcement . The Company has the
requisite corporate power and authority to enter into and to
consummate the transactions contemplated by each of the Transaction
Documents and otherwise to carry out its obligations
hereunder
7
and
thereunder. The execution and delivery of each of the
Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly
authorized by all necessary action on the part of the Company and
no further action is required by the Company, the Board of
Directors or the Company’s stockholders in connection
therewith other than in connection with the Required
Approvals. Each Transaction Document to which it is a party
has been (or upon delivery will have been) duly executed by the
Company and, when delivered in accordance with the terms hereof and
thereof, will constitute the valid and binding obligation of the
Company enforceable against the Company in accordance with its
terms, except (i) as limited by general equitable principles
and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of
creditors’ rights generally, (ii) as limited by laws
relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as
indemnification and contribution provisions may be limited by
applicable law or public policy.
(d)
No Conflicts . The execution, delivery and performance
by the Company of the Transaction Documents, the issuance and sale
of the Securities and the consummation by it of the transactions
contemplated hereby and thereby to which it is a party do not and
will not (i) conflict with or violate any provision of the
Company’s or any Subsidiary’s certificate or articles
of incorporation, bylaws or other organizational or charter
documents, or (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a
default) under, result in the creation of any Lien upon any of the
properties or assets of the Company or any Subsidiary, or give to
others any rights of termination, amendment, acceleration or
cancellation (with or without notice, lapse of time or both) of,
any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other
understanding to which the Company or any Subsidiary is a party or
by which any property or asset of the Company or any Subsidiary is
bound or affected, or (iii) subject to the Required Approvals,
conflict with or result in a violation of any law, rule,
regulation, order, judgment, injunction, decree or other
restriction of any court or governmental authority to which the
Company or a Subsidiary is subject (including federal and state
securities laws and regulations), or by which any property or asset
of the Company or a Subsidiary is bound or affected; except in the
case of each of clauses (ii) and (iii), such as would not
reasonably be expected to result in a Material Adverse
Effect.
(e)
Filings, Consents and Approvals . The Company is not
required to obtain any consent, waiver, authorization or order of,
give any notice to, or make any filing or registration with, any
court or other federal, state, local or other governmental
authority or other Person in connection with the execution,
delivery and performance by the Company of the Transaction
Documents, other than: (i) the filings required pursuant to
Section 4.2 of this Agreement, (ii) the filing with the
Commission of the Prospectus Supplement,
(iii) application(s) to the Trading Market for the
listing of the Securities for trading thereon in the time and
manner required thereby, (iv) such filings as are required to
be made under applicable state securities laws and (v) such
consents, waivers, authorizations or orders, or such filings, as
have been obtained or made (collectively, the “ Required
Approvals ”).
8
(f)
Issuance of the Securities; Registration . The Shares
and Warrants are duly authorized and, when issued and paid for in
accordance with the applicable Transaction Documents, will be duly
and validly issued, fully paid and, in the case of the Shares,
nonassessable, free and clear of all Liens imposed by the
Company. The Warrant Shares, when issued in accordance with
the terms of the Warrants, will be validly issued, fully paid and
nonassessable, free and clear of all Liens imposed by the
Company. The Company has reserved from its duly authorized
capital stock the maximum number of shares of Common Stock issuable
pursuant to this Agreement and the Warrants. The Registration
Statement was declared effective under the Securities Act on
June 30, 2009 and no stop order preventing or suspending the
effectiveness of the Registration Statement or suspending or
preventing the use of the Prospectus has been issued by the
Commission and no proceedings for that purpose have, to the actual
knowledge of the Company, been instituted or are threatened by the
Commission. The Company, if required by the rules and
regulations of the Commission, proposes to file the Prospectus
Supplement with the Commission pursuant to Rule 424(b).
At the time the Registration Statement and any amendments thereto
became effective, at the date of this Agreement and at the Closing
Date, the Registration Statement and any amendments thereto
conformed or will conform in all material respects to the
requirements of the Securities Act and did not and will not contain
any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make
the statements therein not misleading; and the Prospectus and any
amendments or supplements thereto, at the time the Prospectus or
any amendment or supplement thereto was issued and at the Closing
Date, conformed or will conform in all material respects to the
requirements of the Securities Act and did not and will not contain
an untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in light of
the circumstances under which they were made, not
misleading.
(g)
Capitalization . The capitalization of the Company is
substantially as set forth in the Prospectus Supplement, as updated
by the SEC Reports. As of the date of this Agreement, the
Company has not issued any capital stock since its most recently
filed periodic report under the Exchange Act, other than pursuant
to the exercise of employee stock options under the Company’s
stock option plans, the issuance of shares of Common Stock to
employees pursuant to the Company’s employee stock purchase
plans and pursuant to the conversion and/or exercise of Common
Stock Equivalents outstanding as of the date of the most recently
filed periodic report under the Exchange Act. No Person has
any right of first refusal, preemptive right, right of
participation, or any similar right to participate in the
transactions contemplated by the Transaction Documents. As a
result of the purchase and sale of the Securities or pursuant to
equity compensation plans or agreements filed as exhibits to the
SEC Reports, there are no outstanding options, warrants, script
rights to subscribe for, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any
Person any right to subscribe for or acquire, any shares of Common
Stock, or contracts, commitments, understandings or arrangements by
which the Company or any Subsidiary is bound to issue additional
shares of Common Stock or Common Stock Equivalents, in each case
issued by the Company. The issuance and sale of the
Securities will not obligate the Company to issue shares of Common
Stock or other securities to any Person (other than the Purchasers)
and
9
will not result
in a right of any holder of Company securities to adjust the
exercise, conversion, exchange or reset price under any of such
securities. All of the outstanding shares of capital stock of the
Company are validly issued, fully paid and nonassessable, have been
issued in compliance in all material respects with all federal and
state securities laws, and none of such outstanding shares was
issued in violation of any preemptive rights or similar rights to
subscribe for or purchase securities. There are no
stockholders agreements, voting agreements or other similar
agreements with respect to the Company’s capital stock to
which the Company is a party or, to the actual knowledge of the
Company, between or among any of the Company’s
stockholders.
(h)
SEC Reports; Financial Statements . The Company has
complied in all material respects with requirements to file or
furnish, as applicable, all reports, schedules, forms, statements
and other documents under the Securities Act and the Exchange Act,
including pursuant to Section 13(a) or
15(d) thereof, for the one year preceding the date hereof (or
such shorter period as the Company was required by law or
regulation to file or furnish, as applicable, such material) (the
foregoing materials, including the exhibits thereto and documents
incorporated by reference therein, together with the Prospectus and
the Prospectus Supplement, being collectively referred to herein as
the “ SEC Reports ”) on a timely basis or has
received a valid extension of such time and has filed or furnished,
as applicable, any such SEC Reports prior to the expiration of any
such extension. As of their respective dates, the SEC Reports
complied in all material respects with the requirements of the
Securities Act and the Exchange Act, as applicable, and none of the
SEC Reports, when filed or furnished, as applicable, contained any
untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under
which they were made, not misleading. The Company has never been an
issuer subject to the disqualification provisions set forth in
Rule 144(i) under the Securities Act. The financial
statements of the Company included in the SEC Reports have been
prepared in accordance with United States generally accepted
accounting principles (“ GAAP ”) applied on a
consistent basis during the periods involved (except as may be
otherwise specified in such financial statements or the notes
thereto and except that unaudited financial statements may not
contain all footnotes required by GAAP), and fairly present in all
material respects the financial position of the Company and its
consolidated Subsidiaries as of and for the dates thereof and the
results of operations and cash flows for the periods then ended,
subject, in the case of unaudited statements, to normal,
immaterial, year-end audit adjustments.
(i)
Material Changes; Undisclosed Events, Liabilities or
Developments . Since the date of the latest audited
financial statements included within the SEC Reports,
(i) there has been no event, occurrence or development that
has had or that would reasonably be expected to result in a
Material Adverse Effect, (ii) the Company has not materially
altered its method of accounting, (iii) the Company has not
declared or made any dividend or distribution of cash or other
property to its stockholders or purchased, redeemed or made any
agreements to purchase or redeem any shares of its capital stock
and (iv) the Company has not issued any equity securities to
any officer, director or Affiliate, except pursuant to existing
Company stock option or compensation plans.
10
(j)
Litigation
. There is
no action, suit, inquiry, notice of violation, Proceeding or
investigation pending or, to the actual knowledge of the Company,
threatened against or affecting the Company, any Subsidiary or any
of their respective properties before or by any court, arbitrator,
governmental or administrative agency or regulatory authority
(federal, state, county, local or foreign) (collectively, an
“ Action ”) which (i) adversely affects or
challenges the legality, validity or enforceability of any of the
Transaction Documents or the Securities or (ii) would
reasonably be expected to result in a Material Adverse Effect if
there were an unfavorable decision.
(k)
Labor
Relations . No material labor
dispute exists or, to the actual knowledge of the Company, is
imminent with respect to any of the employees of the Company which
would reasonably be expected to result in a Material Adverse
Effect.
(l)
Compliance.
Neither
the Company nor any Subsidiary: (i) is in default under or in
violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a
default by the Company or any Subsidiary under), nor has the
Company or any Subsidiary received notice of a claim that it is in
default under or that it is in violation of, any indenture, loan or
credit agreement or any other agreement or instrument to which it
is a party or by which it or any of its properties is bound
(wh
|